Wird geladen...
Bendamustine in patients with relapsed or refractory multiple myeloma
OBJECTIVE: In patients with multiple myeloma, bendamustine monotherapy is effective as 1(st )and 2(nd )line therapy. However, data for patients with advanced multiple myeloma is rare. METHODS: In this retrospective analysis we have identified 39 patients with relapsed or refractory multiple myeloma...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3351842/ https://ncbi.nlm.nih.gov/pubmed/20159666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-15-1-13 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|